Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers June 26, 2016
Pharmacy Choice - News - Over-the-Counter Drugs - June 26, 2016

Pharmacy News

 Over-the-Counter Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 12 of 12     Go To Page:

6/25/16 - "Methods for Treating Dry Eye Disease by Administering an Il-6r Antagonist" in Patent Application Approval Process (USPTO 20160152717)
By a News Reporter-Staff News Editor at Obesity, Fitness& Wellness Week A patent application by the inventors CAO, Jingtai; HU, Ying; ROMANO, Carmelo; WIEGAND, Stanley J., filed on December 1, 2015, was made available online on June 9, 2016, according to news reporting originating from Washington, D.C., by NewsRx correspondents. This patent appli
6/23/16 - Allergan Announces FDA Approval of Supplemental New Drug Application (sNDA) for AVYCAZ (ceftazidime and avibactam)
Allergan plc, a leading global pharmaceutical company, today announced the U.S. Food and Drug Administration has approved the company's supplemental New Drug Application to update the label for AVYCAZ with clinical data from a Phase 3 trial evaluating the safety and efficacy of AVYCAZ, in combination with metronidazole, for the treatment of co
6/23/16 - International Conference on Harmonisation; Electronic Transmission of Postmarket Individual Case Safety Reports for Drugs and Biologics, Excluding...
SUMMARY: The Food and Drug Administration is announcing the availability of its FDA Adverse Event Reporting System Regional Implementation Specifications for the International Conference on Harmonisation E2B Specification. FDA is making this technical specifications document available to assist interested parties in electronically submitting...
6/23/16 - Iroko Summarizes Low-Dose SoluMatrix NSAID Efficacy And Safety Data At American Association Of Nurse Practitioners National Conference
To support the efforts of nurse practitioners who are on the front lines of treating the hundreds of millions of people living in pain 1 in the United States, Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, today summarizes efficacy and safety data supporting the use of low-do
6/23/16 - Vietnam Phamaceutical Report Q2/2016 Market Report; Launched via MarketResearchReports.com
Market Research Reports, Inc. has announced the addition of Vietnam Phamaceutical Report Q2/2016 research report to their website www.MarketResearchReports.comLewes, DE 06/23/2016 With 178 drug manufacturers Vietnam pharmaceutical products mostly focus on simple dosage forms and generic form with lower values and overlapping, and comple
6/22/16 - Dimension Therapeutics Announces Recombinant DNA Advisory Committee's Unanimous Approval of Phase 1/2 Study Protocol for DTX301, Lead Inherited Metabolic Disease (IMD) Product Candidate to Treat OTC Deficiency
Dimension Therapeutics, Inc., a biopharmaceutical company advancing novel, adeno-associated virus gene therapies targeting the liver, a key organ for human metabolism, today announced unanimous approval by the National Institutes of Health's Recombinant DNA Advisory Committee of a Phase 1/ 2 study protocol for DTX301 for the treatment of Ornithin
6/21/16 - FDA Approves New Drug Application for RAYALDEE to Treat Secondary Hyperparathyroidism Associated with Vitamin D Insufficiency in Stage 3-4 Chronic Kidney Disease
OPKO Health, Inc. announced that the U.S. Food and Drug Administration has approved RAYALDEE extended release capsules for the treatment of secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease and serum total 25- hydroxyvitamin D levels less than 30 ng/mL. Phillip Frost, CEO and Chairman of OPKO. "RAYALDEE is the fir
6/21/16 - Perrigo Announces FDA Clearance And Launch Of Non-GMO* Infant Formulas For The U.S. Store Brand Market
Perrigo Company plc, today announced it has received final U.S. Food and Drug Administration clearance for three milk-based, store brand non-GMO infant formulas. Perrigo introduced non-GMO formulas for consumers who prefer non-GMO versions of existing products. Perrigo's CEO, John T. Hendrickson stated, "We know that today's millennial mom is mor
6/21/16 - Sandoz Canada Launches First Non-Prescription Naloxone Approved by Health Canada for Treating Opioid Overdoses
Sandoz Canada announces the launch of S.O.S. "Sandoz Canada is the first pharmaceutical company in the country to have completed the filing process for non-prescription naloxone. Naloxone? Hydrochloride Injection, "said Michel Robidoux, President and General Manager of Sandoz Canada.
6/21/16 - VANC Pharmaceuticals Receives Health Canada Approval for Van-Fer Tablets and Capsules
BRITISH COLUMBIA, VANCOUVER 06/21/16 VANC Pharmaceuticals Inc., a pharmaceutical company focused on the Canadian generic drug and over-the-counter markets, pleased to announce that it has received the approvals for Van-Fer tablets and capsules. The iron supplements market in Canada is estimated to be around $75 million per annum, based on IMS
6/20/16 - Americans need easier access, more affordable options for hearing health care new report
By a News Reporter-Staff News Editor at Managed Care Weekly Digest WASHINGTON- Hearing loss is a significant public health concern, and efforts should be made to provide adults with easier access to and more affordable options for hearing health care, especially for those in underserved and vulnerable populations, says a new report from the Natio
6/20/16 - VANC Pharmaceuticals Signs Definitive Agreement for Exclusive In-License on a CAD $150M Generic Molecule and soon to be Off Patent Molecule
VANC Pharmaceuticals Inc., a pharmaceutical company focused on the Canadian generic drug and over-the-counter markets, pleased to announce that it has entered into a definitive agreement for filing two abbreviated new drug submissions with exclusive marketing rights to Canada from an unnamed, manufacturer. "We are very excited to have signed this.
Articles(s): 1 - 12 of 12     Go To Page:


© 2016 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415